Eagle’s Eye View: Can apixaban be used safely in patients with AF and end-stage kidney disease?
Listen now
Description
In this week’s View, Dr. Eagle explores the associations of apixaban dose with safety and effectiveness outcomes in patients with atrial fibrillation and severe chronic kidney disease. He then discusses a study that looks at stroke risk in women with atrial fibrillation. Finally, Dr. Eagle examines the DCM Precision Medicine Study of rare variant genetics and dilated cardiomyopathy severity.
Subscribe to Eagle’s Eye View
More Episodes
Published 12/06/23
In this week’s View, Dr. Eagle explores stroke and bleeding risk in patients with atrial fibrillation and a CHA2DS2-VASC risk score of 1. He then discusses the important key points to remember in the recently released 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial...
Published 12/06/23
In this week’s View, Dr. Eagle explores a meta-analysis of direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation. He then discusses a 20-year study of sudden cardiac death in National Collegiate Athletic Association athletes. Finally, Dr. Eagle...
Published 11/22/23
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
